Mah Sing Healthcare secures business licences for glove exports

PETALING JAYA (May 24): Property developer Mah Sing Group Bhd’s wholly-owned unit Mah Sing Healthcare Sdn Bhd has received its business licence and other relevant licences/permits, and operation has commenced at its glove manufacturing factory in Kapar, Klang, said the developer.

In a media statement today, the company said the first shipment of gloves is expected to be delivered in this month or June 2021.

It added that the company has secured sufficient raw materials to meet orders and interests from its buyers and distributors, which are mainly serving markets such as the United States, Canada, Middle East, Europe, United Kingdom, Japan, China, Korea, Singapore, Russia and Latin America. 

In addition, Mah Sing Healthcare has also received the export licence from the Malaysian Rubber Board, which would facilitate the export business for the Group’s glove manufacturing operation. 

Mah Sing Healthcare has obtained two FDA Establishment Licenses for Polymer Nitrile Patient Examination Glove and Latex Patient Examination Glove from the US Food & Drug Administration (FDA), which all glove manufacturers are required to register in order to sell gloves in the US. 

It is also progressing well in obtaining FDA 510(k) Premarket Notification and the Conformitè Europëenne (CE) Marking for export to the US and European markets respectively.

Mah Sing said the execution of the glove venture is on schedule as there will be six production lines on track to be operational in 2Q2021, followed by another six production lines in 3Q2021. 

The maximum production capacity of 12 lines is up to 3.68 billion pieces of gloves per annum. 

Meanwhile, in its property segment, the company is seeing improvement in sentiments towards the property market. 

The developer also set a higher sales target of RM1.6billion for the entire 2021, with 91% of products priced below RM700,000, and 51% below RM500,000. It recorded RM250million new property sales for January and February 2021, and bookings momentum since March 2021 has also picked up substantially. 

“Mah Sing has been actively scouting for good land, with two new acquisitions in 2021 so far. On 4 May 2021, it announced the acquisition of approximately 5-acre prime land in Setapak to be developed into M Astra, which has an estimated gross development value (GDV) of approximately RM618million,” said the statement.

Registration of interest is expected to commence in 3Q2021 for M Astra. The mixed development is planned to have 3-bedroom and 4-bedroom units, with indicative built-up ranging from 850sq ft to 1,030sq ft, and will be affordably priced with an indicative starting price from RM399,000.

Get the latest news @ www.EdgeProp.my

Subscribe to our Telegram channel for the latest stories and updates 

Click here for more property stories